With commercial insurance: Amgen SupportPlus Co-Pay Program — as little as $25 per dose. With Medicare: the Prolia card can’t be used. All 6 foundation funds we checked are closed as of October 12, 2026.
See what this patient owes after assistance →
8 assistance programs for Prolia patients · 1 open today
One manufacturer copay card, for commercial insurance only — Amgen’s free-drug foundation does not cover Prolia.
Select the patient's insurance to see which programs may apply.
Current status · Award amounts · Eligibility · Direct application links October 12, 2026
Checked September 28, 2026 · Source 1 ↗ · Source 2 ↗
Checked September 28, 2026 · Source 1 ↗ · Source 2 ↗
Prolia’s card can’t be used with Medicare. These funds may help. They open and close with donations, so call before telling a Prolia patient no.
Checked September 28, 2026 · Source 1 ↗ · Source 2 ↗
Prolia · Postmenopausal osteoporosis · Commercial insurance
Eligible patients may pay $25 per dose
Example · Prolia · 60 mg · 60 units · commercial plan · deductible met · 20% coinsurance · allowed amounts at the Medicare reference rate
| Without assistance | With Amgen SupportPlus Co-Pay Program (Prolia Co-Pay) | |
|---|---|---|
| Drug responsibility | $358.27 | $25.00 |
| Administration (96372) | $3.07 | $3.07 |
| Patient owes | $361.34 | $28.07 |
Estimated patient savings: $333.27
CareCost calculates the drug and administration lines using the patient’s payer rate and benefits; this example uses the Medicare rate as a reference.
Maximum award $1,000
HealthWell Foundation fund for government-insured patients with Post Menopausal Osteoporosis (confirmed diagnosis).
Checked, and not available for this drug today
Free Amgen Safety Net Foundation for eligible patients
Change the diagnosis to see only the programs that apply to your patient.
Prolia shares its class with Jubbonti (Q5136, Sandoz), Stoboclo (Q5157, Celltrion), Conexxence (Q5158, Fresenius Kabi), Enoby (Q5167, Hikma), billed under their own codes with their own manufacturer programs. The programs above apply to Prolia only. If the payer requires Jubbonti, Stoboclo, Conexxence or Enoby instead of Prolia, use that maker’s program below.
Each Jubbonti, Stoboclo, Conexxence or Enoby card shows the date we last checked that program. Copay cards also say whether they pay the infusion or injection fee.
Each biosimilar also has a 120 mg oncology product, the Xgeva equivalent (Wyost, Osenvelt, Bomyntra and Xtrenbo). Those are not listed here, since this page covers the 60 mg osteoporosis line only.
Sandoz One Source Co-Pay Program (Jubbonti Co-Pay)
Sandoz Patient Assistance Program
Celltrion CARES Co-Pay Program
Celltrion CONNECT Patient Support Program
KabiCare Patient Support Program
| Task | ✓ |
|---|---|
| Find programs for this insurance type | ✓ |
| See whether each program is open | ✓ |
| See maximum award | ✓ |
| Review key eligibility requirements | ✓ |
| Open the official application | ✓ |
| Calculate cost before assistance | ✓ |
| Apply the program benefit | ✓ |
| Calculate what the patient still owes | ✓ |
Commercial insurance — Eligible commercially insured patients may qualify for the Amgen SupportPlus Co-Pay Program. Eligible patients may pay as little as $25 per dose, subject to current program terms. View current program ↑
Medicare — Manufacturer copay savings cannot be used when government insurance is paying for Prolia; the federal Anti-Kickback Statute is why, per HHS OIG guidance on copayment coupons. The Amgen Safety Net Foundation is not a fallback either: its covered-product list does not include Prolia. View current options ↑
Uninsured — Amgen’s own free-drug foundation does not cover this product. The Amgen Safety Net Foundation eligibility page names 16 Amgen medicines — Evenity, its other bone drug, among them — and neither Prolia nor Xgeva is on it (checked September 12, 2026). That leaves three real routes: a denosumab biosimilar at cash price, where Hikma publishes Enoby’s list price as $400 a syringe and $800 a year against Medicare’s $1,791.36 allowed amount for 60 mg of reference Prolia; a hospital or FQHC charity-care policy; or a diagnosis-matched foundation fund when one reopens. Check today’s status ↑
Why fund status matters — Manufacturer programs can change between: OPEN Accepting applications now · WAITLIST Not enrolling immediately · CLOSED Not accepting new applications. Every CareCost program card shows the status and the date it was verified.
Why the product name matters — Prolia and Xgeva bill the same HCPCS code (J0897) but are different products with different assistance programs. Confirm which product the patient is actually prescribed before applying.
Yes. The Amgen SupportPlus Co-Pay Program is Amgen’s current manufacturer savings program. Eligible commercially insured patients may pay as little as $25 per dose. Apply on Prolia.com ↗ Calculate cost with the program →
No. Patients using Medicare or other government-funded insurance to pay for Prolia are not eligible for the manufacturer’s copay card. The Amgen Safety Net Foundation is not a fallback either — its eligibility page lists 16 Amgen products and Prolia is not one of them. Check current options ↑
Not from Amgen. The Amgen Safety Net Foundation’s product picker names 16 medicines — including Evenity, Amgen’s other bone drug — and neither Prolia nor Xgeva appears (checked September 12, 2026). What is left for an uninsured patient is a denosumab biosimilar at cash price (Hikma publishes Enoby’s list price as $400 a syringe, $800 a year), hospital or FQHC charity care, or a diagnosis-matched foundation fund if one reopens. Check today’s status ↑
Data current: programs verified Oct 12, 2026
Amgen SupportPlus Co-Pay Program · Amgen Safety Net Foundation · Sandoz One Source Co-Pay Program · Sandoz Patient Assistance Program (Jubbonti) · Celltrion CARES Co-Pay Program · Celltrion CONNECT Patient Support Program (Stoboclo) · KabiCare Patient Support Program (Conexxence). Every program links directly to its official source or application page.
Last program check: .
Reviewed September 11, 2026 by Erin Rose, CareCost Estimate founder. Methodology →
CareCost